11940541

Source:http://linkedlifedata.com/resource/pubmed/id/11940541

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003440, umls-concept:C0008976, umls-concept:C0027051, umls-concept:C0087111, umls-concept:C0206460, umls-concept:C1274040, umls-concept:C2825951
pubmed:issue	14
pubmed:dateCreated	2002-4-9
pubmed:abstractText	ENTIRE-TIMI 23 evaluated enoxaparin with full-dose tenecteplase (TNK) and half-dose TNK plus abciximab.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/11940541, http://linkedlifedata.com/resource/pubmed/commentcorrection/11940541-12403679
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0147763
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Enoxaparin, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Fab Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/abciximab, http://linkedlifedata.com/resource/pubmed/chemical/tenecteplase
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1524-4539
pubmed:author	pubmed-author:AntmanElliott MEM, pubmed-author:BaarsHubert FHF, pubmed-author:BassandJean-PierreJP, pubmed-author:BigonziFrederiqueF, pubmed-author:BraunwaldEugeneE, pubmed-author:GibsonC MichaelCM, pubmed-author:HamerBasB, pubmed-author:HeidbuchelHeinH, pubmed-author:LouwerenburgHans WHW, pubmed-author:PisapiaGhislaineG, pubmed-author:Van de WerfFransF, pubmed-author:WesdorpJan C LJC
pubmed:issnType	Electronic
pubmed:day	9
pubmed:volume	105
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1642-9
pubmed:dateRevised	2005-11-17
pubmed:meshHeading	pubmed-meshheading:11940541-Aged, pubmed-meshheading:11940541-Antibodies, Monoclonal, pubmed-meshheading:11940541-Anticoagulants, pubmed-meshheading:11940541-Blood Flow Velocity, pubmed-meshheading:11940541-Cohort Studies, pubmed-meshheading:11940541-Coronary Angiography, pubmed-meshheading:11940541-Dose-Response Relationship, Drug, pubmed-meshheading:11940541-Drug Therapy, Combination, pubmed-meshheading:11940541-Electrocardiography, pubmed-meshheading:11940541-Enoxaparin, pubmed-meshheading:11940541-Female, pubmed-meshheading:11940541-Fibrinolytic Agents, pubmed-meshheading:11940541-Hemorrhage, pubmed-meshheading:11940541-Heparin, pubmed-meshheading:11940541-Humans, pubmed-meshheading:11940541-Immunoglobulin Fab Fragments, pubmed-meshheading:11940541-Male, pubmed-meshheading:11940541-Middle Aged, pubmed-meshheading:11940541-Myocardial Infarction, pubmed-meshheading:11940541-Platelet Aggregation Inhibitors, pubmed-meshheading:11940541-Recurrence, pubmed-meshheading:11940541-Risk Assessment, pubmed-meshheading:11940541-Survival Rate, pubmed-meshheading:11940541-Tissue Plasminogen Activator, pubmed-meshheading:11940541-Treatment Outcome
pubmed:year	2002
pubmed:articleTitle	Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.
pubmed:affiliation	Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, Mass, USA. eantman@rics.bwh.harvard.edu
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Multicenter Study